Medwatch sent to the fda.A review of the instructions for use notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "other-clinical outcome device related" as follows: warnings: only physicians possessing sufficient skill and experience in similar or the same techniques should perform endoscopic procedures.Ensure that there is sufficient space for the needle to open.Warning: do not introduce the device with the needle body in its open position.Adverse event: possible complications that may result from using the endoscopic suturing system include, but may not be limited to: abdominal pain and / or bloating, pharyngeal, colonic and/or esophageal perforation, esophageal, colonic and/or pharyngeal laceration, intra-abdominal (hollow or solid) visceral injury.
|
Supplement #2 medwatch submitted to the fda on 08/oct/2020.Device evaluation summary: the device was returned to the apollo device analysis laboratory on 30/apr/2020.A needle driver and anchor exchange was received for evaluation.The needle body tip appeared to be straight.When the closing lever was depressed, the needle body appeared to rest in a center position within the alignment tube.The endcap holder was installed on the endcap for testing and alignment pin a2 was used.When the handle was depressed, the needle body tip entered the alignment pin hole without bending or flexing.The device locked into place when the closing lever was depressed.An in-house suture anchor was loaded into the anchor exchange, and the exchange was advanced into the endcap holder.When the needle driver was actuated, the anchor engaged to the needle body.This test was successfully repeated several times.At no time during suture enabling sequence did the anchor drop unintentionally from the needle body tip.
|